Expiration date: 06/2026

Action: 

Bronchogelatinous 

Composition: 

Formoterol 0.012 mg 

Indications:

Prevention and treatment of bronchial obstruction in patients with bronchial asthma in combination with corticosteroids therapy, in patients with COPD